MARSHALL WACE, LLP

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in AQST

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,188,340

+$1,112,333 QoQ

Shares Held

285,659

+1459.7% QoQ

Ownership

0.228%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 185 holders

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. AQST ranks #19 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HIMS	Hims & Hers Health, Inc.	4,217,767	$146,229,981
2	ELAN	Elanco Animal Health Inc	4,432,350	$109,080,132
3	LNTH	Lantheus Holdings, Inc.	773,978	$85,865,119
4	ALKS	Alkermes plc.	969,954	$50,825,589
5	NBIX	Neurocrine Biosciences Inc	270,754	$45,632,878
6	RDY	Dr Reddys Laboratories Ltd	2,025,356	$29,347,408
7	AMPH	Amphastar Pharmaceuticals, Inc.	1,066,322	$21,518,377
8	ZTS	Zoetis Inc.	257,470	$18,501,794

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,188,340	285,659	+1459.7%	Shares	Other	2026-08-13
2026-03-31	$76,007	18,315	-95.1%	Shares	Other	2026-05-15
2025-09-30	$2,074,258	371,066	+411.3%	Shares	Other	2025-11-13
2025-06-30	$240,236	72,579	+30.3%	Shares	Other	2025-08-13
2024-12-31	$198,274	55,695	-27.7%	Shares	Other	2025-02-13
2024-06-30	$200,241	77,016	-73.3%	Shares	Other	2024-08-14
2023-12-31	$583,545	288,884	-7.1%	Shares	Other	2024-02-14
2023-09-30	$475,537	310,809	+14.1%	Shares	Other	2023-11-14
2023-06-30	$449,451	272,395	—	Shares	Other	2023-08-14
No filing history on record for this holder in this stock.